Senior insider sale
SVP, Head of Res./Clin. Dev. at ABEONA THERAPEUTICS INC. — senior position signals high conviction
$574.4K
87.58K shares
What this filing means
SESHADRI VISHWAS plans to sell 87.58K shares of ABEONA THERAPEUTICS INC. valued at approximately $574.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/29/2026ACC: 0001972481-26-000288
Officer· SVP, Head of Res./Clin. Dev.
Since Jun 2021
87.58K
Shares to sell
$574.4K
Approx. market value
38.80K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Awards
Equity Compensation
9/29/2026
38.80KTotal acquired38.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/29/2026 | Restricted Stock Awards Equity Compensation | 38.80K | — |
| Total | 38.80K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
67.97K
Market value
$473.3K
7/9/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
19.61K
Market value
$101.1K
9/29/2026
Total
Units
87.58K
Value
$574.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/9/2026 | 67.97K | $473.3K | — | Completed |
| Planned — Approximate Date | ||||
9/29/2026 | 19.61K | $101.1K | Nasdaq | Planned |
| Total | 87.58K | $574.4K | ||